MD-2 as the target of curcumin in the inhibition of response to LPS
The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Abstract
Curcumin is the main constituent of the spice turmeric, used in diet and in traditional medicine, particularly across the Indian subcontinent. Anti-inflammatory activity and inhibition of LPS signaling are some of its many activities. We show that curcumin binds at submicromolar affinity to the myeloid differentiation protein 2 (MD-2), which is the LPS-binding component of the endotoxin surface receptor complex MD-2/TLR4. Fluorescence emission of curcumin increases with an absorbance maximum shift toward the blue upon the addition of MD-2, indicating the transfer of curcumin into the hydrophobic environment. Curcumin does not form a covalent bond to the free thiol group of MD-2, and C133F mutant retains the binding and inhibition by curcumin. The binding site for curcumin overlaps with the binding site for LPS. This results in the inhibition of MyD88-dependent and -independent signaling pathways of LPS signaling through TLR4, indicating that MD-2 is one of the important targets of curcumin in its suppression of the innate immune response to bacterial infection. This finding, in addition to the correlation between the dietary use of curcumin and low incidence of gastric cancer in India, may have important implications for treatment and epidemiology of chronic inflammatory diseases caused by bacterial infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The immunopathogenesis of sepsis
Cohen, J. (2002) · Nature · doi:10.1038/nature01326 · Cited by 2,742 · cited 1×
“The innate immune response to LPS enables cells to respond quickly to the bacterial infection; however, this response can become deregulated and may lead to inflammation, which can progress to sepsis with frequent fatal consequences [3].”
BackgroundMolecular targets of dietary agents for prevention and therapy of cancer
Aggarwal, B. B., & Shishodia, S. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.02.009 · Cited by 1,754 · cited 1×
“Curcumin, an extended pseudosymmetric polyphenol, has a variety of biological activities, including anti-inflammatory properties, which have been attributed to its antioxidant activity as well as to direct interaction with protein targets [17].”
BackgroundActivation of Transcription Factor NF-κB Is Suppressed by Curcumin (Diferuloylmethane)
Singh, S., & Aggarwal, B. B. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.42.24995 · Cited by 1,386
Seong, S.-Y., & Matzinger, P. (2004) · Nature Reviews Immunology · doi:10.1038/nri1372 · Cited by 1,220 · cited 1×
“Agonists of the TLRs, particularly of TLR4, originating from microorganisms or of the endogenous origin, are hydrophobic and have been proposed to represent the “ancient danger signal” [ 43 ], which could be inhibited by molecules of the natural origin such as curcumin, which inhibits the cytokine signaling at differe…”
BackgroundTlr4: central component of the sole mammalian LPS sensor
Beutler, B. (2000) · Current Opinion in Immunology · doi:10.1016/s0952-7915(99)00046-1 · Cited by 762 · cited 2×
“A cellular response to LPS is initiated by the interaction of LPS with the transmembrane complex myeloid differentiation protein 2 (MD-2)/TLR4, including participation of extracellular LPS-binding proteins, LBP and CD14 [1, 2].”
BackgroundComalada, M., Ballester, I., Bailón, E., Sierra, S., Xaus, J., Gálvez, J., Medina, F. S. D., & Zarzuelo, A. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.07.016 · Cited by 440 · cited 1×
“For several polyphenols, it has been demonstrated that they inhibit the NF- B activation initiated by bacterial LPS, but in most cases, the molecular target has not been clearly established [15, 16].”
BackgroundCharacterization of quercetin binding site on DNA gyrase
Plaper, A., Golob, M., Hafner, I., Oblak, M., Šolmajer, T., & Jerala, R. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)01006-4 · Cited by 369 · cited 1×
“squared equation, taking into account the ligand depletion [21].”
BackgroundSelf-citationSalt, salted food intake, and risk of gastric cancer: Epidemiologic evidence
Tsugane, S. (2005) · Cancer Science · doi:10.1111/j.1349-7006.2005.00006.x · Cited by 354 · cited 1×
“Genetic predisposition cannot be the reason for this “Asian enigma,” as the rate of gastric cancer is decreased significantly in Japanese emigrants to the Americas [38].”
BackgroundMD-2 Binds to Bacterial Lipopolysaccharide
Viriyakosol, S., Tobias, P. S., Kitchens, R. L., & Kirkland, T. N. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105228200 · Cited by 312 · cited 1×
“We have shown previously that MD-2 contains one free thiol group [13], which is according to the model, at Position 133.”
BackgroundSaitoh, S.-I. (2004) · International Immunology · doi:10.1093/intimm/dxh097 · Cited by 236 · cited 1×
“MD-2 has been identified as the target of LPS antagonists mimicking lipid A [29, 30].”
Background
Cited by
Aggarwal, B. B., & Sung, B. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2008.11.002 · Cited by 1,140
Multitargeting by curcumin as revealed by molecular interaction studies
Gupta, S. C., Prasad, S., Kim, J. H., Patchva, S., Webb, L. J., Priyadarsini, I. K., & Aggarwal, B. B. (2011) · Natural Product Reports · doi:10.1039/c1np00051a · Cited by 669
TLR4 Signaling Pathway Modulators as Potential Therapeutics in Inflammation and Sepsis
Kuzmich, N., Sivak, K., Chubarev, V., Porozov, Y., Savateeva-Lyubimova, T., & Peri, F. (2017) · Vaccines · doi:10.3390/vaccines5040034 · Cited by 633
Morphine activates neuroinflammation in a manner parallel to endotoxin
Wang, X., Loram, L. C., Ramos, K., de Jesus, A. J., Thomas, J., Cheng, K., Reddy, A., Somogyi, A. A., Hutchinson, M. R., Watkins, L. R., et al. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1200130109 · Cited by 517
Weisberg, S. P., Leibel, R., & Tortoriello, D. V. (2008) · Endocrinology · doi:10.1210/en.2008-0262 · Cited by 480
Curcumin: an orally bioavailable blocker of TNF and other pro‐inflammatory biomarkers
Aggarwal, B. B., Gupta, S. C., & Sung, B. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12131 · Cited by 395
Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?
Brown, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4675 · Cited by 359
Toll‐like receptor 4 in CNS pathologies
Buchanan, M. M., Hutchinson, M., Watkins, L. R., & Yin, H. (2010) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2010.06736.x · Cited by 336
Saleh, H. A., Yousef, M. H., & Abdelnaser, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.606069 · Cited by 255
Therapeutic targeting of innate immunity with Toll-like receptor 4 (TLR4) antagonists
Peri, F., & Piazza, M. (2012) · Biotechnology Advances · doi:10.1016/j.biotechadv.2011.05.014 · Cited by 162
“A more detailed analysis of the molecular mechanism of action, revealed that curcumin very likely binds to MD-2 thus competing with LPS (Gradisar et al., 2007).”
BackgroundInfluential
Metadata
- Authors
- Gradišar, H., Keber, M. M., Pristovšek, P., & Jerala, R.
- Venue
- Journal of Leukocyte Biology
- Publisher
- Oxford University Press (OUP)
- Published
- 2007-07-03
- Volume
- 82
- Issue
- 4
- Pages
- 968-974
- ISSN
- 0741-5400 (ISSN-L)
- 1938-3673
- OpenAlex
- W2140040520
- Cited by
- 159
- References
- 40
- FWCI
- 3.35
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.